Drug middlemen illegally drive up the cost of insulin, FTC says, exposing a hidden layer of price manipulation in the pharmaceutical supply chain. These middlemen, who act as intermediaries between manufacturers and pharmacies, are accused of exploiting their position to inflate insulin prices, ultimately burdening patients and the healthcare system. …
Read More »FTC Accuses Drug Middlemen of Inflating Insulin Prices
Federal Trade Commission accuses three drug middlemen of inflating insulin prices sets the stage for this enthralling narrative, offering readers a glimpse into a story that is rich in detail and brimming with originality from the outset. The FTC alleges that these middlemen, who act as intermediaries in the pharmaceutical …
Read More »